Adlai Nortye Ltd. reported $5.0M of revenue over the trailing twelve months. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $5.0M (to FY2025). Net income: −$36M, trailing twelve months to FY2025. Free cash flow: −$34M, trailing twelve months to FY2025. Operating margin: −714%, trailing twelve months to FY2025.

ANLAdlai Nortye Ltd.

Healthcare

$10.59+542% 1Y

$10.59

$0.8852 weeks$16.60

ANL as reported

Adlai Nortye Ltd. reported $5.0M of revenue over the trailing twelve months. 9 reported series are charted on this page, each one as filed.

$5.0M

Revenue, trailing twelve months · to FY2025 · every figure below is as filed, with no scoring applied

Net income: −$36M
Net income · −32% year on year · trailing twelve months to FY2025
Free cash flow: −$34M
Free cash flow · −35% year on year · trailing twelve months to FY2025
Operating margin: −714%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for ANL, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$5.0M	n/a	FY2025
Net income	−$36M	−32%	FY2025
EPS	−$0.37	−31%	FY2025
Operating margin	−714%	n/a	FY2025
Net margin	−711%	n/a	FY2025
ROE	427%	n/a	FY2025
ROA	−103%	n/a	FY2025
ROIC	−344%	n/a	FY2025
Free cash flow	−$34M	−35%	FY2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.